Zobrazeno 1 - 10
of 16
pro vyhledávání: '"T Roshni, Paul"'
Autor:
T SRAVANI, PAMU PRAMOD KUMAR, ASWANI TANDON, MEGHA S UPPIN, SHANTIVEER G UPPIN, AMVR NARENDRA, GUNDETI SADASHIVUDU, T ROSHNI PAUL
Publikováno v:
National Journal of Laboratory Medicine, Vol 8, Iss 4, Pp PO08-PO12 (2019)
Introduction: Acute Promyelocytic Leukaemia (APL/APML) is an uncommon haematologic malignancy associated with translocation t (15; 17) and presence of abnormal promyelocytes in the peripheral blood and bone marrow. Aim: To know the clinico-pathol
Externí odkaz:
https://doaj.org/article/250bc62091184b2381b78c282f089f5c
Publikováno v:
Journal of Clinical and Scientific Research, Vol 6, Iss 2, Pp 125-128 (2017)
A male agricultural worker, aged 50 years was admitted with fever of 60 days. He had generalized weakness and headache. He was febrile. Anaemia (haemoglobin 11.7g/dL) and thrombocytopenia (platelet count 80,000/mm3) were evident. He also developed he
Externí odkaz:
https://doaj.org/article/81170b5aa2104af687356e71bac4e69e
Publikováno v:
Journal of Clinical and Scientific Research, Vol 3, Iss 4, Pp 268-273 (2014)
Antiretroviral therapy in human immunodeficiency virus (HIV) patients has prolonged survival and reduced the frequency of opportunistic infections (OI). However, following starting of antiretroviral therapy (ART), some patients experience a paradoxic
Externí odkaz:
https://doaj.org/article/7c12e80d43094dde802d1e50350d1c81
Autor:
Amvr Narendra, T Sravani, Megha S Uppin, Shantiveer Uppin, Pamu Pramod Kumar, Gundeti Sadashivudu, T Roshni Paul, Aswani Tandon
Publikováno v:
National Journal of Laboratory Medicine, Vol 8, Iss 4, Pp PO08-PO12 (2019)
Introduction: Acute Promyelocytic Leukaemia (APL/APML) is an uncommon haematologic malignancy associated with translocation t (15; 17) and presence of abnormal promyelocytes in the peripheral blood and bone marrow. Aim: To know the clinico-pathologic
Autor:
G Rajeswari, T Roshni Paul, Megha S. Uppin, Shantveer G. Uppin, D Raghunadha Rao, D Sree Bhushan Raju D, G Sadashindu
Publikováno v:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
Plasma cell leukemia (PCL) is a rare and aggressive variant of plasma cell dyscrasia. They occur de novo (primary) or as a late manifestation of multiple myeloma (secondary). Patients present with anemia, thrombocytopenia, renal failure, organomegaly
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology. 22(4)
Autor:
Rachel Jacob, D. Raghunadha Rao, Shantveer G Uppin, Senthil Rajappa, T Roshni Paul, Megha S Uppin
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 26:56-61
Imatinib Mesylate, a Tyrosine Kinase inhibitor, is presently the drug of choice for Chronic myeloid leukemia (CML). During therapy, a few patients develop myelosuppression and present with cytopenias. To study the bone marrow morphology in imatinib t
Publikováno v:
Endocrine pathology. 26(4)
Neoplastic plasma cell involvement of thyroid is an uncommon condition, and it may involve thyroid in multiple myeloma or solitary plasmacytoma. Its clinical and pathological features are not well understood. We present a rare case of synchronous thy
Autor:
D Raghunadharao, Megha S Uppin, Shantveer G Uppin, Rachel Jacob, T Roshni Paul, Bheemanathi Hanuman Srinivas
Imatinib mesylate (Gleevec) is an effective treatment for chronic myeloid leukemia (CML). Though cytogenetic and molecular analyses are essential disease monitoring parameters in CML bone marrow morphological response is not well defined. We examined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b85f4664853aefe4e7474e0569fd319
https://europepmc.org/articles/PMC3422382/
https://europepmc.org/articles/PMC3422382/
Autor:
Megha S, Uppin, T Roshni, Paul, Senthil, Rajappa, K, Gayathri, Rachel, Jacob, Shantveer G, Uppin
Publikováno v:
Indian journal of pathologymicrobiology. 50(3)
To study the occurrence of leukemia as a second malignancy following various primary solid and hematological malignancies. Total 11 cases of leukemia presenting as a second malignancy were studied over a period of 15 years from 1990 to 2005. The prim